The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy

Immune checkpoint inhibitors have revolutionized treatment and outcome of melanoma and many other solid malignancies including non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC). Unfortunately, only a minority of patients have a long-term benefit, while the remaining demonstrate prima...

Full description

Bibliographic Details
Main Authors: Andrea Botticelli, Alessio Cirillo, Simone Scagnoli, Bruna Cerbelli, Lidia Strigari, Alessio Cortellini, Laura Pizzuti, Patrizia Vici, Federica De Galitiis, Francesca Romana Di Pietro, Edoardo Cerbelli, Michele Ghidini, Giulia D’Amati, Carlo Della Rocca, Silvia Mezi, Alain Gelibter, Raffaele Giusti, Enrico Cortesi, Paolo Antonio Ascierto, Marianna Nuti, Paolo Marchetti
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Vaccines
Subjects:
immunotherapy
agnostic biomarkers
predictive factors
prognostic factors
metastatic sites
melanoma
Online Access:https://www.mdpi.com/2076-393X/8/2/203

Internet

https://www.mdpi.com/2076-393X/8/2/203

Similar Items